Your session is about to expire
← Back to Search
Cognitive Behavioral Therapy
Executive Function Treatment for Autism Spectrum Disorder
N/A
Waitlist Available
Led By Lauren Kenworthy, PhD
Research Sponsored by Children's National Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, end of intervention (up to end of academic year, approx 9 months)
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a school-based program called UOT:HS for high school students with autism. The program aims to improve planning and flexibility skills through lessons and parental involvement to help students succeed after high school.
Who is the study for?
This trial is for high school students with autism spectrum disorder who have an IQ of 80 or higher and are in mainstream classes at least 20% of the time. They must also show signs of social communication challenges. Students and caregivers must be proficient in English to participate.
What is being tested?
The study tests 'Unstuck & On Target: High School' (UOT:HS), a program designed to improve flexibility and planning skills among autistic youth. It involves school staff delivering lessons, check-ins by study staff, and parent trainings to extend learning at home.
What are the potential side effects?
As UOT:HS is a behavioral intervention focusing on executive function skills rather than medication, it does not have typical medical side effects. However, participants may experience stress or frustration as they learn new strategies.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, end of intervention (up to end of academic year, approx 9 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, end of intervention (up to end of academic year, approx 9 months)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adaptive Behavior (at follow-up)
Classroom Behavior
Secondary study objectives
Adaptive Behavior (end of intervention)
Other study objectives
Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2)
Dimensional Change Card Sort - NIH Toolbox
Executive Function Challenge Task (EFCT)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
Participants in schools assigned to the TAU condition will continue to receive the standard school-based Individualized Education Plan (IEP) accommodations and school supports that would typically be provided.
Group II: Intervention (Unstuck & On Target: High School)Experimental Treatment1 Intervention
School staff will receive training on the Unstuck and On Target: High School (UOT:HS) curriculum, and deliver lessons to students during the school day. Interventionists will have the option to participate in ongoing check-ins with study staff. Parents are provided home extensions for each lesson and have the option to participate in trainings delivered by study staff to support generalization of skills to the home environment.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Cognitive-behavioral interventions like the Unstuck & On Target High School (UOT:HS) program focus on enhancing executive function skills, including flexibility and planning, by teaching strategies to manage and adapt to changing situations. These skills are essential for daily functioning and successful transitions into adulthood for individuals with ASD.
Other common treatments include behavioral-based interventions, which use reinforcement techniques to improve specific behaviors, and developmental models that focus on social communication and emotional regulation. These treatments are important as they address core deficits in ASD, helping individuals improve their social interactions, communication, and adaptive behaviors, ultimately leading to better long-term outcomes.
[Fragile X syndrome: new therapeutic strategies].Neurologic treatment strategies in autism: an overview of medical intervention strategies.[Good practice guidelines for the treatment of autistic spectrum disorders].
[Fragile X syndrome: new therapeutic strategies].Neurologic treatment strategies in autism: an overview of medical intervention strategies.[Good practice guidelines for the treatment of autistic spectrum disorders].
Find a Location
Who is running the clinical trial?
Children's National Research InstituteLead Sponsor
221 Previous Clinical Trials
258,146 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
132 Patients Enrolled for Autism Spectrum Disorder
Lauren Kenworthy, PhDPrincipal InvestigatorChildren's Research Institute, Children's National Hospital
1 Previous Clinical Trials
97 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
97 Patients Enrolled for Autism Spectrum Disorder
Cara Pugliese, PhDPrincipal InvestigatorChildren's Research Institute, Children's National Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The student spends at least 20% of their time in mainstream educational services, as identified in their IEP or through teacher report.Your parents or teachers have reported that you have difficulty with social communication, scoring 11 or higher on a questionnaire.You have been diagnosed with autism by a healthcare professional or have an educational classification for autism.Someone who is considered to have a full scale IQ of 80 or higher is considered to have an above-average intelligence
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Intervention (Unstuck & On Target: High School)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger